New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model

Journal of Heart and Lung Transplantation

Volumn 19, Issue 11, 2000, Pages 1047-1055

  Richter, Markus ^a,c   Skupin, Manfred ^b   Grabs, Robert ^b   Schramm, David ^b   Richter, Heike ^b   Olbrich, Hans Georg ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Experimental Heart Transplant Group   (Germany)

^c Head of Experimental Heart Transplant Group   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IMMUNOSUPPRESSIVE AGENT; LOSARTAN; PLATELET DERIVED GROWTH FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT OUTCOME;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CORONARY DISEASE; CORONARY VESSELS; CYCLOSPORINE; ENALAPRIL; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; LOSARTAN; MALE; PREMEDICATION; RATS; RATS, INBRED F344; RATS, INBRED LEW; TRANSPLANTATION, HETEROTOPIC;

EID: 0033757752     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(00)00197-2     Document Type: Article

References (36)

1. Myocardial changes in cardiac transplant-associated coronary arteriosclerosis: Potential for timely diagnosis
2. The pathogenesis of atherosclerosis: A perspective for the 1990's
3. Captopril reduces graft coronary artery disease in a rat heterotopic transplant model
4. Local expression and pathobiological role of renin-angiotensin in the blood vessels and heart
5. Angiotensin II induces vascular smooth muscle cell replication independent of blood pressure
6. Potential importance of tissue angiotensin converting enzyme inhibition in preventing neointimal formation
7. Losartan but not Verapamil inhibits angiotensin II induced tissue endothelin-1 increase. Role of blood pressure and endothelial function
8. Angiotensin II can regulate gene expression by the AP-1 binding sequence via a protein kinase C-dependent pathway
9. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall
10. Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts
11. Inhibitors of the angiotensin-converting enzyme prevent myointimal injury after vascular injury
12. TCV-116 reduces chronic rejection in a rat heterotopic cardiac transplant model
13. Experimental graft arteriosclerosis. I. The Lewis to Fisher F344 allograft model
14. Lymphocytic subsets and histopathologic changes associated with the development of heart transplant atherosclerosis
15. Improved technique of heart transplantation in rats
16. A working formulation for the standardisation of nomenclature in the diagnosis of heart and lung rejection: Heart rejection study group
17. Angiotensin-converting enzyme: New concepts concerning its biological role
18. Angiotensin II formation from ACE and chymase in human and animal hearts: Methods and species consideration
19. Molecular biology of angiotensin II receptors: An overview
20. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury
21. Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of the rat aorta
22. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: Gain-of function study using gene transfer
23. Angiotensin II receptors and angiotensin II receptors antagonists
24. The potential role of angiotensin II in the vasculature
25. Effect of Captopril on the bradykinin-induced release of prostacyclin from guinea pig lung or bovine aortic endothelial cell
26. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation
27. Hormone interaction in the isolated rabbit heart. Synthesis and coronary vasomotor effects of prostaglandins, angiotensin and bradykinin
28. Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery
29. Angiotensin II stimulates calcium-dependent activation of c-Jun N-terminal kinase
30. Angiotensin II stimulates MAP kinase activity in vascular smooth muscle cells, role of Raf
31. c-Jun N-terminal phosphorilation correlates with activation of JNK subgroup but not the ERK subgroups of mitogen-activated protein kinases
32. The regulation of AP-1 activity by mitogen-activated protein kinases
33. Stimulation by endothelin-1 of mitogen activated protein kinases and DNA synthesis in bovine tracheal smooth muscle cells
34. Angiotensin converting enzyme inhibition abolished medial smooth muscle PDGF-AB biosynthesis and attenuates cell proliferation in injured carotid arteries. Relationship to neointima formation
35. Effect of bradykinin on prostaglandin production by human skin fibroblasts in culture
36. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II